Peter A. Kiener, Director at Cue Biopharma, Inc. (CUE), sold 38,991 shares at $17.92 ($699K) on 2021-11-15, disclosed to the SEC on 2021-11-17.
Open-market sale of $699k CUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.92 | 18,815 | $337K | 48.2% |
| 2 | $17.92 | 18,815 | $337K | 48.2% |
| 3 | $18.02 | 1,361 | $25K | 3.5% |
| Total | $17.92 avg | 38,991 | $699K | 100% |
| Filing → |
| MEDI | SELL | 2006-02-09 | $401K | — | Filing → |